+28.2%
MRNA vs PAAS
+255.3%
-227.2%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | PAAS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +3.7% | -7.1% | -4.9% |
| 7D | -10.1% | +2.6% | -12.7% | -11.1% |
| 30D | +126.7% | +2.5% | +124.3% | +122.8% |
| 3M | +184.1% | +15.1% | +169.0% | +171.2% |
| 6M | +143.3% | -12.1% | +155.3% | +144.7% |
| YTD | +359.9% | +3.1% | +356.8% | +347.3% |
| 1Y | +454.2% | +50.8% | +403.3% | +402.5% |
| All | +28.2% | +255.3% | -227.2% | -6.6% |
Cumulative growth
Daily Returns
Daily percentage return beside PAAS.
Daily Out/Under-Performance
Portfolio return minus PAAS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PAAS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded PAAS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling